Gyre Therapeutics Inc.
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 34.1 | 16.7 | 4.7 | – | 120.1 | – | – | – | – | 102.4 | 108.3 | 152.8 | 113.2 | 141.0 | – | – | |
| 489.1 | 294.5 | 228.1 | 486.4 | 427.7 | 914.6 | 4,620.2 | – | – | – | – | – | – | – | – | – | – | 99.8 | 351.9 | 366.1 | 278.5 | 58.4 | 69.5 | 34.4 | 6.0 | 4.9 | 1.7 | 3.3 | 4.8 | 17.4 | 15.5 | 11.1 | 12.2 | 11.7 | 7.8 | 6.3 | 7.0 | 6.1 | 5.3 | 5.6 | |
| 10.9 | 7.3 | 9.2 | 9.0 | 13.3 | 30.3 | 24.4 | 15.3 | 14.9 | 11.8 | 13.7 | 14.3 | 10.9 | 18.0 | 9.9 | 14.5 | 15.1 | 27.5 | 20.5 | 23.7 | 31.8 | 10.4 | 17.1 | 21.5 | 10.8 | 11.9 | 30.0 | 3.8 | 156.8 | – | 31.7 | 20.6 | 20.3 | 19.5 | 11.5 | 7.2 | 7.6 | 6.9 | 6.3 | 5.1 | |
| 535.8 | 317.5 | 224.8 | 439.1 | 420.6 | 905.3 | – | – | – | – | – | – | – | – | – | – | – | 98.4 | 338.3 | 353.1 | 270.2 | 52.7 | 64.6 | 32.9 | 5.7 | 4.7 | 1.7 | 3.1 | – | 17.1 | 15.3 | 11.0 | 12.1 | 11.6 | 7.7 | 5.9 | 6.6 | 5.8 | 5.0 | 5.2 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 32.6 | – | 100.6 | 69.0 | 47.7 | 67.8 | 49.6 | 45.4 | 65.9 | 54.7 | 54.1 | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 21.4 | 8.4 | 8.5 | 9.8 | 113.3 | 158.2 | 557.7 | – | – | – | – | 571.0 | – | 210.7 | – | |
| -8.9% | -16.2% | -14.4% | -6.9% | -5.7% | -2.1% | -0.6% | -1.1% | -1.3% | -2.0% | -2.7% | -3.2% | -5.1% | -3.6% | -3.5% | -2.3% | -2.9% | -2.6% | -3.5% | -4.0% | -4.6% | -19.7% | -11.7% | -2.9% | -7.4% | 4.7% | 12.0% | 11.8% | 10.2% | 0.9% | 0.6% | 0.2% | -0.2% | -0.6% | -1.3% | -0.3% | 0.2% | -0.1% | 0.5% | -2.5% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| -2,239.4% | -2,549.7% | -6,262.7% | -10,859.1% | -7,941.4% | -8,618.9% | -8,553.1% | – | – | – | – | – | – | – | – | – | – | 56.0% | -2.6% | -2.3% | -2.9% | -2.3% | -4.1% | -0.6% | 36.2% | 53.5% | 62.2% | 95.6% | 95.9% | 95.9% | 96.1% | 96.3% | 96.2% | 96.3% | 96.2% | 96.0% | 95.6% | 95.5% | 95.2% | 94.3% | |
| -4,560.3% | -5,130.4% | -3,574.6% | -3,745.0% | -2,751.4% | -2,143.6% | -3,231.1% | – | – | – | – | – | – | – | – | – | – | -273.9% | -1,235.6% | -1,399.5% | -1,247.3% | -1,197.8% | -1,202.7% | -133.6% | -47.4% | -11.0% | 8.0% | 18.6% | 25.3% | -59.3% | -56.9% | -60.5% | -72.4% | 15.3% | 10.4% | 4.7% | 6.9% | 5.9% | -3.8% | -14.0% | |
| -4,203.2% | -4,257.8% | -3,123.6% | -3,298.2% | -2,536.7% | -2,118.0% | -2,983.4% | – | – | – | – | – | – | – | – | – | – | -268.5% | -1,233.7% | -1,399.7% | -1,248.5% | -1,198.3% | -1,200.8% | -17.2% | 17.6% | 29.6% | 37.2% | -2.4% | 4.0% | -81.9% | -75.8% | -77.0% | -84.6% | 11.4% | 7.2% | 4.1% | 6.2% | 4.3% | -5.1% | -14.5% | |
| -4,376.4% | -4,758.8% | -3,286.1% | -3,367.8% | -2,428.7% | -1,961.0% | -2,785.3% | – | – | – | – | – | – | – | – | – | – | -264.1% | -1,237.6% | -1,451.8% | -1,285.5% | -1,152.8% | -815.7% | -98.8% | -44.5% | 23.1% | 20.9% | 38.7% | 49.0% | 15.3% | 9.8% | 2.0% | -2.3% | -6.6% | -10.5% | -1.6% | 1.2% | -0.8% | 2.5% | -14.1% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -93.5% | -105.4% | -126.4% | -61.1% | -78.6% | -70.1% | -15.7% | -16.8% | -19.2% | -25.1% | -37.9% | -50.9% | -64.5% | -80.7% | -45.3% | -43.7% | -54.2% | -73.9% | -71.7% | -90.8% | -142.4% | -214.0% | -295.5% | -10.7% | 31.6% | 71.2% | 639.7% | -2.8% | 130.6% | – | -154.7% | -142.5% | -140.6% | 19.1% | 10.6% | 4.7% | 6.7% | 4.9% | -6.1% | -13.3% | |
| -35.5% | -44.5% | -60.2% | -46.8% | -56.9% | -54.6% | -15.4% | -16.5% | -18.7% | -24.1% | -35.8% | -47.0% | -57.1% | -56.0% | -39.9% | -38.5% | -45.6% | -59.3% | -62.7% | -75.9% | -110.2% | -158.0% | -198.7% | -10.2% | 15.8% | 35.7% | 251.0% | -2.4% | 46.1% | -79.7% | -71.8% | -71.1% | -70.9% | 9.6% | 5.6% | 2.8% | 4.3% | 3.1% | -3.8% | -8.7% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| 20 | 9.1 | -1.9 | -27 | -5.5 | -9.4 | – | – | – | – | -25 | -17 | -23 | -15 | -70 | -59 | -24 | -30 | -82 | -72 | -57 | -42 | -33 | -74 | -25 | -25 | -7.6 | -21 | – | -33 | -30 | -15 | -15 | -11 | -14 | -36 | -40 | -36 | -37 | -42 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -2.0 | – | -1.7 | -1.2 | -0.6 | -0.8 | -0.4 | -0.8 | -3.8 | -3.0 | -2.8 | – | – | |
| 38.0% | 42.2% | 47.6% | 76.6% | 72.3% | 77.9% | 97.9% | 98.2% | 97.4% | 96.0% | 94.6% | 92.3% | 88.5% | 69.3% | 88.2% | 88.1% | 84.1% | 80.2% | 87.4% | 83.7% | 77.3% | 73.8% | 67.2% | 94.8% | 50.2% | 50.2% | 39.2% | 87.7% | 35.3% | -13.6% | 46.4% | 49.9% | 50.4% | 50.5% | 52.5% | 60.3% | 63.9% | 63.8% | 62.5% | 65.4% | |
| 1.5 | 1.2 | 0.9 | 0.2 | 0.2 | 0.2 | – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -23.20 | -21.14 | -19.31 | -4.78 | -4.54 | -4.72 | -2.50 | -1.93 | -2.09 | -2.51 | -3.35 | -3.95 | -4.36 | -4.58 | -3.03 | -2.66 | -2.31 | -2.54 | -2.63 | -2.47 | -2.76 | -2.80 | -1.71 | -0.13 | 0.22 | 0.48 | 0.67 | -0.04 | 0.06 | -1.21 | -0.85 | -0.82 | -0.87 | 0.12 | 0.07 | 0.05 | 0.07 | 0.05 | -0.07 | -0.17 | |
| 0.55 | 0.50 | 0.62 | 0.14 | 0.18 | 0.22 | 0.08 | – | – | – | – | – | – | – | – | – | – | 0.95 | 0.21 | 0.18 | 0.22 | 0.23 | 0.14 | 0.78 | 1.25 | 1.61 | 1.80 | 1.60 | 1.50 | 1.48 | 1.13 | 1.07 | 1.02 | 1.03 | 0.99 | 1.18 | 1.07 | 1.16 | 1.31 | 1.19 | |
| 24.82 | 20.05 | 15.27 | 7.83 | 5.77 | 6.74 | 15.89 | 11.47 | 10.88 | 10.04 | 8.84 | 7.77 | 6.76 | 5.68 | 6.68 | 6.09 | 4.26 | 3.44 | 3.67 | 2.72 | 1.94 | 1.31 | 0.58 | 1.26 | 0.70 | 0.67 | 0.10 | 1.39 | 0.05 | -0.21 | 0.55 | 0.58 | 0.62 | 0.62 | 0.67 | 1.03 | 0.99 | 1.03 | 1.11 | 1.30 | |
| -24.16 | -23.63 | -20.31 | -4.88 | -4.34 | -4.37 | -2.33 | -2.01 | -2.18 | -2.42 | -3.23 | -3.56 | -3.72 | -3.63 | -2.30 | -2.08 | -1.87 | -2.50 | -2.64 | -2.56 | -2.84 | -2.69 | -1.16 | -0.77 | -0.56 | 0.37 | 0.38 | 0.62 | 0.73 | 0.23 | 0.11 | 0.02 | -0.02 | -0.07 | -0.10 | -0.02 | 0.01 | -0.01 | 0.03 | -0.17 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.